Rapacuronium administration to two children with Duchenne's muscular dystrophy.
Children with Duchenne's muscular dystrophy should not be exposed to succinylcholine because of the risk of hyperkalemic cardiac arrest and rhabdomyolysis. This report describes the response to rapacuronium bromide in two patients with Duchenne's muscular dystrophy. Both patients had a recovery index 2 times longer than that reported in children with normal neuromuscular function.
Frankowski
G A
GA
Department of Anesthesiology, University of Missouri, Columbia 65212, USA.
Johnson
J O
JO
Tobias
J D
JD
D000768:Anesthesia, General; D002648:Child; D004576:Electromyography; D005260:Female; D006801:Humans; D008297:Male; D020388:Muscular Dystrophy, Duchenne / Q000503:physiopathology; D009466:Neuromuscular Blocking Agents; D019637:Orthopedic Procedures; D014673:Vecuronium Bromide / Q000031:analogs & derivatives*
D009466:Neuromuscular Blocking Agents; D014673:Vecuronium Bromide; C082938:rapacuronium